AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11268375 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic treatment with antidepressants (imipramine or fluoxetine)
Number of subjects: 0
Study 9351765 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 gel
Number of subjects: 443
Study 9351765 — intervention group
Group type: COMPARATOR
Intervention: Hygroscopic dilation
Number of subjects: 443
Study 8222498 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg ketoprofen
Number of subjects: 240
Study 8222498 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg ketoprofen
Number of subjects: 240
Study 8222498 — intervention group
Group type: EXPERIMENTAL
Intervention: 650 mg acetaminophen plus 10 mg oxycodone hydrochloride
Number of subjects: 240
Study 8222498 — intervention group
Group type: COMPARATOR
Intervention: 650 mg acetaminophen
Number of subjects: 240
Study 8222498 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 3952172 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-interval 90-sec schedule
Number of subjects: 66
Study 3952172 — intervention group
Group type: COMPARATOR
Intervention: Random-interval 90-sec schedule
Number of subjects: 66
Study 3952172 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 66
Study 29989486 — intervention group
Group type: EXPERIMENTAL
Intervention: 2,000 steps/day (STEP group)
Number of subjects: 17
Study 29989486 — intervention group
Group type: COMPARATOR
Intervention: No intervention (CON group)
Number of subjects: 17
Study 30340708 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye examinations performed in shelters for children and AYFM
Number of subjects: 49
Study 27852246 — intervention group
Group type: EXPERIMENTAL
Intervention: Central hole ICL
Number of subjects: 22
Study 27852246 — intervention group
Group type: COMPARATOR
Intervention: Conventional ICL
Number of subjects: 22
Study 24824288 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced diet (higher amounts of energy, protein, lipids, vitamin A, arachidonic acid, and docosahexaenoic acid)
Number of subjects: 48
Study 24824288 — intervention group
Group type: COMPARATOR
Intervention: Standard diet
Number of subjects: 48
Study 24824288 — intervention group
Group type: EXPERIMENTAL
Intervention: All infants (both groups)
Number of subjects: 48
Study 24824288 — intervention group
Group type: EXPERIMENTAL
Intervention: Small for gestational age (SGA) infants
Number of subjects: 48
Study 23516055 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibrotactile feedback from an array of eight stimulators on the forearm
Number of subjects: 10
Study 23516055 — intervention group
Group type: COMPARATOR
Intervention: No feedback about the hand opening
Number of subjects: 10
Study 23516055 — intervention group
Group type: EXPERIMENTAL
Intervention: Three levels of distraction (no distraction, counting task, count and subtract task)
Number of subjects: 10
Study 20345708 — intervention group
Group type: EXPERIMENTAL
Intervention: PAI-749
Number of subjects: 12
Study 20345708 — intervention group
Group type: COMPARATOR
Intervention: Control (t-PA)
Number of subjects: 12
Study 20345708 — intervention group
Group type: EXPERIMENTAL
Intervention: Blocking antibody against PAI-1
Number of subjects: 12
Study 18544975 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fat diet (diet I)
Number of subjects: 78
Study 18544975 — intervention group
Group type: EXPERIMENTAL
Intervention: Low carbohydrate diet (diet II)
Number of subjects: 78
Study 15882368 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing
Number of subjects: 60
Study 15882368 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 60
Study 15882368 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 60
Study 15882368 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 60
Study 12623738 — intervention group
Group type: EXPERIMENTAL
Intervention: High-structure, behaviorally-oriented (HSB) individual counseling
Number of subjects: 143
Study 12623738 — intervention group
Group type: COMPARATOR
Intervention: Low-structure, facilitative (LSF) individual counseling
Number of subjects: 143
Study 10561210 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral medroxyprogesterone acetate 200 mg/d
Number of subjects: 299
Study 10561210 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral medroxyprogesterone acetate 1,000 mg/d
Number of subjects: 299
Study 8739857 — intervention group
Group type: EXPERIMENTAL
Intervention: anti-CD4 monoclonal antibody/prednisolone
Number of subjects: 12
Study 8739857 — intervention group
Group type: COMPARATOR
Intervention: multiple injections of insulin alone
Number of subjects: 12
Study 1928949 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol (2.5 mg) followed by allergen
Number of subjects: 10
Study 1928949 — intervention group
Group type: COMPARATOR
Intervention: Placebo followed by allergen
Number of subjects: 10
Study 1928949 — intervention group
Group type: COMPARATOR
Intervention: Albuterol followed by saline
Number of subjects: 10
Study 6405650 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral disodium cromoglycate (DSCG) 200 mg qid for adults, 100 mg qid for children
Number of subjects: 24
Study 6405650 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 31711168 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR tools plus coaching (coaching group)
Number of subjects: 194
Study 31711168 — intervention group
Group type: COMPARATOR
Intervention: EHR tools (tracking group)
Number of subjects: 194
Study 29570853 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa-carbidopa intestinal gel
Number of subjects: 262
Study 26596400 — intervention group
Group type: EXPERIMENTAL
Intervention: Ahmed Glaucoma Valve FP7
Number of subjects: 276
Study 26596400 — intervention group
Group type: COMPARATOR
Intervention: Baerveldt Glaucoma Implant BG 101‐350
Number of subjects: 276
Study 25086831 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocular Response Analyzer (ORA) with Narafilcon A (1‐Day Acuvue True Eye)
Number of subjects: 28
Study 25086831 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocular Response Analyzer (ORA) with Nelfilcon A (Daily AquaComfort Plus)
Number of subjects: 28
Study 25086831 — intervention group
Group type: COMPARATOR
Intervention: Ocular Response Analyzer (ORA) without soft contact lenses
Number of subjects: 28
Study 21985338 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery with tape
Number of subjects: 60
Study 21985338 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery with perceived happy memory
Number of subjects: 60
Study 21985338 — intervention group
Group type: COMPARATOR
Intervention: Control (individualized therapy without guided imagery)
Number of subjects: 60
Study 19616166 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program consisting of three sessions between the educator and persons with diabetes
Number of subjects: 50
Study 19616166 — intervention group
Group type: COMPARATOR
Intervention: Control group (no education)
Number of subjects: 50
Study 17196453 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 985
Study 17196453 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy with LDL <100 mg/dl
Number of subjects: 985
Study 17196453 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy with LDL >=100 mg/dl
Number of subjects: 985
Study 17196453 — intervention group
Group type: COMPARATOR
Intervention: No statin therapy (Control)
Number of subjects: 985
Study 15272394 — intervention group
Group type: EXPERIMENTAL
Intervention: Abacavir
Number of subjects: 111
Study 15272394 — intervention group
Group type: COMPARATOR
Intervention: Thymidine analogues
Number of subjects: 111
Study 12410892 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifocal glasses wearers
Number of subjects: 156
Study 12410892 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular multifocal glasses use
Number of subjects: 156
Study 9822313 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 microg/kg subcutaneous octreotide
Number of subjects: 23
Study 9822313 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 microg/kg subcutaneous octreotide
Number of subjects: 23
Study 9822313 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous octreotide (both doses)
Number of subjects: 23
Study 9822313 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous octreotide
Number of subjects: 23
Study 8086018 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic carpal tunnel release
Number of subjects: 0
Study 8086018 — intervention group
Group type: COMPARATOR
Intervention: Open carpal tunnel release
Number of subjects: 0
Study 2509186 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal intermittent-release nitroglycerin system (10 mg nitroglycerin, daily for eight days)
Number of subjects: 24
Study 2509186 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo plaster, daily for eight days)
Number of subjects: 24
Study 30473202 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual hypnotherapy
Number of subjects: 354
Study 30473202 — intervention group
Group type: EXPERIMENTAL
Intervention: Group hypnotherapy
Number of subjects: 354
Study 30473202 — intervention group
Group type: COMPARATOR
Intervention: Educational supportive therapy (control)
Number of subjects: 354
Study 30473202 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotherapy (both groups combined)
Number of subjects: 354
Study 28355511 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA (docosahexaenoic acid) at a dose of 60 mg per kilogram of body weight per day
Number of subjects: 1273
Study 28355511 — intervention group
Group type: COMPARATOR
Intervention: Control (soy emulsion without DHA)
Number of subjects: 1273
Study 28355511 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA
Number of subjects: 1273
Study 28355511 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 1273
Study 29911602 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% nitrous oxide and oxygen
Number of subjects: 70
Study 29911602 — intervention group
Group type: COMPARATOR
Intervention: 50% oxygen in air
Number of subjects: 70
Study 29911602 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (N2O and 50% O2)
Number of subjects: 70
Study 23964933 — intervention group
Group type: EXPERIMENTAL
Intervention: Vedolizumab (300 mg)
Number of subjects: 1576
Study 23964933 — intervention group
Group type: EXPERIMENTAL
Intervention: Vedolizumab every 8 weeks
Number of subjects: 1576
Study 23964933 — intervention group
Group type: EXPERIMENTAL
Intervention: Vedolizumab every 4 weeks
Number of subjects: 1576
Study 23964933 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1576
Study 23964933 — intervention group
Group type: EXPERIMENTAL
Intervention: Vedolizumab
Number of subjects: 1576
Study 21397251 — intervention group
Group type: EXPERIMENTAL
Intervention: Generating delayed keywords prior to judging comprehension
Number of subjects: 0
Study 21397251 — intervention group
Group type: COMPARATOR
Intervention: Control condition (not specified)
Number of subjects: 0
Study 21397251 — intervention group
Group type: EXPERIMENTAL
Intervention: Generating delayed keywords
Number of subjects: 0
Study 18389332 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (10 mg/day) plus Atorvastatin (20 mg/day)
Number of subjects: 126
Study 18389332 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine (10 mg/day)
Number of subjects: 126
Study 16849078 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-headed toothbrush (TH-TB)
Number of subjects: 94
Study 15358643 — intervention group
Group type: EXPERIMENTAL
Intervention: Photopheresis
Number of subjects: 40
Study 15358643 — intervention group
Group type: COMPARATOR
Intervention: Sham pheresis (placebo)
Number of subjects: 40
Study 11379837 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone (mean daily dose 2.9 mg, range 1.5-4 mg)
Number of subjects: 38
Study 11379837 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 11379837 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 38
Study 9404739 — intervention group
Group type: EXPERIMENTAL
Intervention: Transbronchial biopsy (TBB) with hematoxylin-eosin staining
Number of subjects: 105
Study 9404739 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall assessment of TBB
Number of subjects: 105
Study 9404739 — intervention group
Group type: EXPERIMENTAL
Intervention: Transbronchial biopsy (TBB)
Number of subjects: 105
Study 7971429 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver Quality of Life Index (CQLI)
Number of subjects: 130
Study 7971429 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospice Quality of Life Index (HQLI)
Number of subjects: 130
Study 7971429 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver's perception of the patient's quality of life
Number of subjects: 130
Study 7971429 — intervention group
Group type: EXPERIMENTAL
Intervention: CQLI
Number of subjects: 130
Study 3310529 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour distributed message group
Number of subjects: 9
Study 3310529 — intervention group
Group type: EXPERIMENTAL
Intervention: Chamber REST (various groups)
Number of subjects: 9
Study 3310529 — intervention group
Group type: EXPERIMENTAL
Intervention: Flotation REST
Number of subjects: 9
Study 30648112 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinopathy
Number of subjects: 6068
Study 30648112 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropathy
Number of subjects: 6068
Study 27044557 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous thiamine (200 mg)
Number of subjects: 64
Study 27044557 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 26679768 — intervention group
Group type: EXPERIMENTAL
Intervention: Practical Approach to Lung Health strategy intervention
Number of subjects: 0
Study 26679768 — intervention group
Group type: EXPERIMENTAL
Intervention: Training of informal health providers
Number of subjects: 0
Study 26679768 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 24300152 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg once daily
Number of subjects: 100
Study 24300152 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 100
Study 20439065 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplement only
Number of subjects: 2069
Study 20439065 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium/vitamin D supplement
Number of subjects: 2069
Study 20439065 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplement only
Number of subjects: 2069
Study 20439065 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiosteoporosis medications
Number of subjects: 2069
Study 18421460 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational leaflet on prostate cancer screening methods
Number of subjects: 1500
Study 18421460 — intervention group
Group type: COMPARATOR
Intervention: No educational leaflet (only physician information during interview)
Number of subjects: 1500
Study 16391243 — intervention group
Group type: EXPERIMENTAL
Intervention: Above-the-elbow cast
Number of subjects: 102
Study 16391243 — intervention group
Group type: COMPARATOR
Intervention: Below-the-elbow cast
Number of subjects: 102
Study 16391243 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 102
Study 12772751 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirenzepine eye drops
Number of subjects: 0
Study 10900497 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 micrograms/kg clonidine
Number of subjects: 150
Study 10900497 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 micrograms/kg midazolam
Number of subjects: 150
Study 10900497 — intervention group
Group type: COMPARATOR
Intervention: No premedication (control)
Number of subjects: 150
Study 8610922 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholesterol-reducing drugs
Number of subjects: 0
Study 8610922 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonpharmacologic interventions
Number of subjects: 0
Study 8610922 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 1407926 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous and oral magnesium
Number of subjects: 98
Study 1407926 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous and oral terbutaline
Number of subjects: 98
Study 1407926 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral magnesium
Number of subjects: 98
Study 1407926 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous terbutaline
Number of subjects: 98
Study 4018179 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin (0.25 mg/day) for 8 weeks
Number of subjects: 15
Study 28816242 — intervention group
Group type: EXPERIMENTAL
Intervention: Basimglurant 0.5 mg
Number of subjects: 183
Study 28816242 — intervention group
Group type: EXPERIMENTAL
Intervention: Basimglurant 1.5 mg
Number of subjects: 183
Study 28816242 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 183
Study 27604770 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA (400 mg/day)
Number of subjects: 1094
Study 27604770 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1094
Study 24884739 — intervention group
Group type: EXPERIMENTAL
Intervention: E-learning course on delirium for nursing staff
Number of subjects: 3263
Study 24884739 — intervention group
Group type: COMPARATOR
Intervention: Control phase (no e-learning course)
Number of subjects: 3263
Study 24884739 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention phase (with e-learning course)
Number of subjects: 3263
Study 22239205 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone follow-up
Number of subjects: 77
Study 22239205 — intervention group
Group type: EXPERIMENTAL
Intervention: Short message service
Number of subjects: 77
Study 19926261 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducation
Number of subjects: 1178
Study 18547293 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg morphine in 10 ml saline
Number of subjects: 25
Study 18547293 — intervention group
Group type: COMPARATOR
Intervention: 10 ml saline
Number of subjects: 25
Study 16463864 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermia (34 degrees C maintained for 72 hours)
Number of subjects: 72
Study 16463864 — intervention group
Group type: COMPARATOR
Intervention: Normothermia (control group)
Number of subjects: 72
Study 12186794 — intervention group
Group type: EXPERIMENTAL
Intervention: Omapatrilat (40 mg once daily)
Number of subjects: 5770
Study 12186794 — intervention group
Group type: COMPARATOR
Intervention: Enalapril (10 mg BID)
Number of subjects: 5770
Study 9933261 — intervention group
Group type: EXPERIMENTAL
Intervention: Nausea/vomiting within 24 hours after onset
Number of subjects: 135
Study 9933261 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic blood pressure >/=180 mm Hg within 12 hours
Number of subjects: 135
Study 9933261 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypodensity of >50% of the middle cerebral artery territory on initial CT scan
Number of subjects: 135
Study 7748048 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 162
Study 7748048 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 162
Study 7748048 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162
Study 7748048 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen and Naproxen
Number of subjects: 162
Study 7748048 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 162
Study 2359741 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity intervention programs focusing on changing eating patterns
Number of subjects: 0
Study 2359741 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity intervention programs focusing on weight loss and weight-loss management
Number of subjects: 0
Study 565645 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG mixed with irradiated autologous melanoma cells
Number of subjects: 15
Study 565645 — intervention group
Group type: COMPARATOR
Intervention: Control group (no further treatment)
Number of subjects: 15
Study 565645 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 15
Study 31152048 — intervention group
Group type: EXPERIMENTAL
Intervention: Early palliative care
Number of subjects: 0
Study 31152048 — intervention group
Group type: COMPARATOR
Intervention: First-line chemotherapy
Number of subjects: 0
Study 28495026 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured postoperative physiotherapy (combined neck-specific exercises with a behavioral approach)
Number of subjects: 202
Study 28495026 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured postoperative physiotherapy (with ≥50% attendance)
Number of subjects: 202
Study 28495026 — intervention group
Group type: COMPARATOR
Intervention: Standard postoperative approach
Number of subjects: 202
Study 25958108 — intervention group
Group type: EXPERIMENTAL
Intervention: Decisional Conflict Scale (DCS) subscale - values clarity
Number of subjects: 332
Study 25958108 — intervention group
Group type: EXPERIMENTAL
Intervention: Decisional Conflict Scale (DCS) subscale - support
Number of subjects: 332
Study 25958108 — intervention group
Group type: EXPERIMENTAL
Intervention: Decisional Conflict Scale (DCS) subscale - effective decision
Number of subjects: 332
Study 25958108 — intervention group
Group type: EXPERIMENTAL
Intervention: Full Decisional Conflict Scale (DCS)
Number of subjects: 332
Study 24250318 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine wound infiltration (40 ml, 0.25%)
Number of subjects: 46
Study 24250318 — intervention group
Group type: COMPARATOR
Intervention: Saline control (40 ml, 0.9%)
Number of subjects: 46
Study 21336630 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine (ALC) plus methylphenidate (20-30 mg/day depending on weight)
Number of subjects: 40
Study 21336630 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus methylphenidate (20-30 mg/day depending on weight)
Number of subjects: 40
Study 19169651 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) therapy initiated within 24 hours of surgery
Number of subjects: 29
Study 19169651 — intervention group
Group type: COMPARATOR
Intervention: Phenytoin (PHT) therapy continued
Number of subjects: 29
Study 19169651 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV)
Number of subjects: 29